跳至主要内容
临床试验/NCT06404723
NCT06404723尚未招募不适用

The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients

Sohag University0 个研究点目标入组 150 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
主要终点
Fibrinogen/Albumin ratio, C-reactive protein /Albumin ratio

研究概览

简要总结

The aim of the study was to study the predictive value of FAR and CAR in order to provide a new predictive biomarkers for the disease activity and prognosis.

详细描述

A total of 150 participants were included in a Case-Control study:

  1. Healthy control group: this group contains 50 healthy individual.
  2. Lupus simplex (mild and moderate disease activity) group: this group contains 50 patients with a systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K) score less than 15.
  3. Severe disease activity group: this group contains 50 patients with a systemic lupus erythematosus disease activity index 2000 (SLEDAI-2K) score ≥ 15.

Setting:

This study will be conducted to All patients will enter to The Rheumatology Department, Sohag University Hospital for one year.

Inclusion criteria:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed as SLE according to SLICC 2012 or ACE/EULAR 2017 classification criteria with
  • ≥18 years of age.
  • Complete clinical and laboratory investigations.
  • No concomitant infection, systemic or other autoimmune diseases.

排除标准

  • Patients were excluded from the study if they had any of the following:
  • <18 years of age,
  • Incomplete clinical data and laboratory indicators.
  • End-stage kidney disease (defned as requiring dialysis, kidney transplantation, or estimated glomerular fltration rate (eGFR)<15 mL/min/1.73 m2
  • Patients with:
  • Acute infectious diseases, HIV infection carriers,
  • Concomitant systemic diseases such as chronic obstructive lung disease, coronary artery disease, cancer, thyroid function disorder, hematological disorders, acute or chronic liver and renal diseases.
  • Patients with had other autoimmune diseases, such as rheumatoid arthritis, systemic sclerosis, or primary Sjogren's syndrome.

结局指标

主要结局

Fibrinogen/Albumin ratio, C-reactive protein /Albumin ratio

时间窗: 1-6-2024 to 1-6-2025

detect if the results approve their use as a predictive and prognostic tools for SLE

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Manar Gamal Mohamed

Specialist of Physical Medicine, Rheumatology and Rehabilitation at Medical Admintsration at Sohag University

Sohag University

相似试验